$278.18
1.620.59%
In chiusura: -
$278.18
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Labcorp Hldgs. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Labcorp Hldgs.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Labcorp Holdings Inc addetti ai lavori?
A Labcorp Holdings Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 14.85K azioni del valore di $4.05M, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno luglio 31, 2025, Peter J Wilkinson, l'azienda SVP, CHIEF ACCOUNTING OFFICER sold 202 condivisioni per $261.02 ciascuna.
- Il giorno giugno 12, 2025, Kerrii B Anderson, l'azienda DIRECTOR sold 500 condivisioni per $260 ciascuna.
- Il giorno luglio 2, 2025, Kerrii B Anderson, l'azienda DIRECTOR sold 500 condivisioni per $265 ciascuna.
Statistiche sulla proprietà per Labcorp Holdings Inc
Numero di azioni emesse
83.100M
Azioni possedute dagli insider
1.268M
Percentuale posseduta dagli Insider
1.53%
Azioni possedute dagli investitori istituzionali
60.252M
Percentuale posseduta dagli investitori istituzionali
72.5%
Aug 15, 2025 | EVP, CHIEF LEGAL OFFICER | 0.00 | $201.43 | -$546.40K | SELL-OPTIONS | 0.00% | 2.27K | Aug 13 | ||
Aug 13, 2025 | PRESIDENT & CEO | -5.64K | $266.78 | -$1.51M | SELL | -5.70% | 93.32K | Aug 11 | ||
Aug 01, 2025 | DIRECTOR | -2.00K | $264.95 | -$529.90K | SELL | -23.11% | 6.66K | Jul 30 | ||
Jul 31, 2025 | SVP, CHIEF ACCOUNTING OFFICER | -202.00 | $261.02 | -$52.73K | SELL | -9.83% | 1.85K | Jul 29 | ||
Jul 28, 2025 | DIRECTOR | -3.50K | $280.00 | -$980.00K | SELL | -28.77% | 8.67K | Jul 24 | ||
Jul 28, 2025 | DIRECTOR | -3.50K | $280.00 | -$980.00K | SELL | -28.77% | 8.67K | Jul 24 | ||
Jul 02, 2025 | DIRECTOR | -500.00 | $265.00 | -$132.50K | SELL | -3.90% | 12.31K | Jul 01 | ||
Jun 12, 2025 | DIRECTOR | -500.00 | $260.00 | -$130.00K | SELL | -3.76% | 12.81K | Jun 11 | ||
Jun 05, 2025 | EVP, PRES ED, CMO & CSO | -2.00K | $247.00 | -$494.00K | SELL | -6.24% | 30.07K | Jun 03 | ||
May 13, 2025 | PRESIDENT & CEO | -6.11K | $248.73 | -$1.52M | SELL | -5.81% | 98.96K | May 12 | ||
May 05, 2025 | EVP, CHIEF LEGAL OFFICER | -1.90K | $238.36 | -$452.88K | SELL | -45.85% | 2.24K | May 01 | ||
May 05, 2025 | SVP, CHIEF ACCOUNTING OFFICER | -829.00 | $242.26 | -$200.84K | SELL | -28.75% | 2.05K | May 01 | ||
Mar 31, 2025 | EVP, CHIEF MARKETING OFFICER | 757.00 | $231.67 | -$305.80K | GRANT | 16.66% | 5.30K | Mar 27 - Mar 28 | ||
Mar 31, 2025 | EVP, PRES DIAGNOSTICS & COO | 0.00 | $231.67 | -$1.12M | GRANT | 0.00% | 4.96K | Mar 27 - Mar 28 | ||
Mar 07, 2025 | DIRECTOR | -500.00 | $255.63 | -$127.82K | SELL | -3.62% | 13.31K | Mar 05 | ||
Mar 04, 2025 | EVP, PRES DIAGNOSTICS & COO | -1.44K | $190.33 | -$817.67K | SELL | -22.45% | 4.96K | Feb 28 | ||
Feb 27, 2025 | EVP, CHIEF LEGAL OFFICER | -1.31K | $251.30 | -$330.21K | SELL | -37.71% | 2.17K | Feb 25 | ||
Feb 26, 2025 | EVP, CHIEF MARKETING OFFICER | -226.00 | $250.40 | -$56.59K | SELL | -4.74% | 4.54K | Feb 24 | ||
Feb 20, 2025 | SVP, CHIEF ACCOUNTING OFFICER | -351.00 | $204.86 | -$116.53K | SELL | -14.97% | 1.99K | Aug 01 - Feb 18 | ||
Feb 13, 2025 | PRESIDENT & CEO | -4.38K | $244.71 | -$1.80M | SELL | -4.74% | 88.18K | Feb 11 | ||
Jan 08, 2025 | DIRECTOR | -1.00K | $235.00 | -$235.00K | SELL | -7.21% | 12.87K | Jan 07 | ||
Dec 04, 2024 | EXECUTIVE VICE PRESIDENT | 0.00 | $226.32 | -$330.50K | SELL-OPTIONS | 0.00% | 31.29K | Dec 02 | ||
Dec 04, 2024 | DIRECTOR | -1.00K | $241.00 | -$241.00K | SELL | -11.48% | 7.71K | Dec 02 | ||
Nov 26, 2024 | EVP, CHIEF MARKETING OFFICER | 343.50 | $203.71 | -$200.53K | SELL-OPTIONS | 8.64% | 4.32K | Nov 22 | ||
Nov 25, 2024 | EVP, CHIEF LEGAL OFFICER | -1.00K | $239.42 | -$239.42K | SELL | -27.25% | 2.67K | Nov 21 | ||
Nov 13, 2024 | PRESIDENT & CEO | -6.19K | $243.47 | -$1.51M | SELL | -6.61% | 87.44K | Nov 11 | ||
Oct 25, 2024 | DIRECTOR | -1.00K | $230.00 | -$230.00K | SELL | -6.73% | 13.87K | Oct 24 | ||
Aug 21, 2024 | EVP, CHIEF LEGAL OFFICER | -2.00K | $227.05 | -$454.10K | SELL | -35.27% | 3.67K | Aug 19 | ||
Aug 19, 2024 | CHIEF FINANCIAL OFFICER, EVP | -15.00K | $223.99 | -$3.36M | SELL | -32.41% | 31.29K | Aug 15 | ||
Aug 09, 2024 | DIRECTOR | -1.00K | $225.00 | -$225.00K | SELL | -6.30% | 14.87K | Aug 07 - Aug 08 | ||
Aug 07, 2024 | EVP, CIO & CTO | -12.09K | $229.10 | -$2.77M | SELL | -43.17% | 15.92K | Aug 05 | ||
May 16, 2024 | EVP, CHIEF LEGAL OFFICER | -2.00K | $210.83 | -$421.66K | SELL | -26.19% | 5.64K | May 14 | ||
May 02, 2024 | DIRECTOR | -500.00 | $202.12 | -$101.06K | SELL | -3.06% | 15.87K | Apr 30 - May 02 | ||
May 01, 2024 | SVP, CHIEF ACCOUNTING OFFICER | -2.44K | $204.33 | -$498.36K | SELL | -53.89% | 2.09K | Apr 29 | ||
Apr 03, 2024 | EVP, PRES DIAGNOSTICS & COO | -6.48K | $217.29 | -$1.41M | SELL | -56.26% | 5.04K | Apr 01 | ||
Apr 03, 2024 | EVP, CHIEF MARKETING OFFICER | -3.50K | $217.29 | -$760.51K | SELL | -46.82% | 3.98K | Apr 01 | ||
Mar 29, 2024 | EVP, CHIEF LEGAL OFFICER | 0.00 | $216.67 | -$1.33M | SELL-OPTIONS | 0.00% | 7.64K | Mar 27 - Mar 28 | ||
Mar 11, 2024 | EVP, PRES DIAGNOSTICS & COO | -2.93K | $167.77 | -$854.62K | SELL | -36.77% | 5.04K | Mar 07 | ||
Mar 11, 2024 | EVP, CHIEF MARKETING OFFICER | -227.00 | $218.45 | -$49.59K | SELL | -5.56% | 3.86K | Mar 07 | ||
Feb 22, 2024 | CHIEF FINANCIAL OFFICER, EVP | -20.45K | $189.80 | -$5.15M | SELL | -46.43% | 23.59K | Feb 21 | ||
Feb 22, 2024 | EVP, PRES, CENTRAL LABS & INTL | -500.00 | $215.49 | -$107.75K | SELL | -12.82% | 3.40K | Feb 21 | ||
Feb 15, 2024 | EVP, CHIEF LEGAL OFFICER | -237.00 | $226.45 | -$53.67K | SELL | -3.01% | 7.64K | Feb 13 | ||
Feb 09, 2024 | EVP, CHIEF LEGAL OFFICER | -259.00 | $222.06 | -$57.51K | SELL | -3.28% | 7.64K | Feb 08 | ||
Feb 06, 2024 | EVP, CHIEF LEGAL OFFICER | 0.00 | $220.83 | -$58.30K | SELL-OPTIONS | 0.00% | 7.64K | Feb 02 - Feb 05 | ||
Nov 20, 2023 | SVP, CHIEF ACCOUNTING OFFICER | -1.38K | $210.71 | -$291.63K | SELL | -39.87% | 2.09K | Nov 16 | ||
Aug 10, 2023 | DIRECTOR | -5.00K | $211.57 | -$1.06M | SELL | -24.49% | 15.42K | Aug 08 | ||
Jul 03, 2023 | EVP, CHIEF LEGAL OFFICER | -212.00 | $240.00 | -$50.88K | SELL | -2.71% | 7.60K | Jun 29 | ||
May 23, 2023 | CEO, COVANCE DRUG DEVELOPMENT | 0.00 | $199.71 | -$147.91K | SELL-OPTIONS | 0.00% | 12.95K | May 19 | ||
May 22, 2023 | EVP, PRES DIAGNOSTICS & COO | 0.00 | $173.69 | -$129.25K | SELL-OPTIONS | 0.00% | 6.69K | May 18 | ||
Apr 03, 2023 | EVP, PRESIDENT-DIAGNOSTICS LAB | 0.00 | $225.34 | -$1.52M | GRANT | 0.00% | 6.69K | Mar 30 - Mar 31 | ||
Feb 23, 2023 | CEO, COVANCE DRUG DEVELOPMENT | -5.00K | $216.55 | -$1.46M | SELL | -35.54% | 9.07K | Feb 21 | ||
Feb 16, 2023 | EVP, PRESIDENT-DIAGNOSTICS LAB | -309.00 | $247.63 | -$76.52K | SELL | -4.42% | 6.69K | Feb 14 | ||
Feb 09, 2023 | EVP, CHIEF LEGAL OFFICER | -219.00 | $243.01 | -$53.22K | SELL | -3.94% | 5.34K | Feb 07 | ||
Feb 09, 2023 | EVP, PRESIDENT-DIAGNOSTICS LAB | -409.00 | $243.01 | -$99.39K | SELL | -5.76% | 6.69K | Feb 07 | ||
Feb 06, 2023 | EVP, CHIEF LEGAL OFFICER | 0.00 | $254.19 | -$60.24K | SELL-OPTIONS | 0.00% | 5.34K | Feb 02 - Feb 03 | ||
Feb 06, 2023 | EVP, PRESIDENT-DIAGNOSTICS LAB | 0.00 | $254.19 | -$112.61K | SELL-OPTIONS | 0.00% | 6.69K | Feb 02 - Feb 03 | ||
Nov 10, 2022 | EVP, PRESIDENT-DIAGNOSTICS LAB | -1.12K | $232.67 | -$259.66K | SELL | -14.30% | 6.69K | Nov 08 | ||
Sep 28, 2022 | CHIEF FINANCIAL OFFICER, EVP | -25.00K | $210.62 | -$5.27M | SELL | -47.93% | 27.16K | Sep 26 | ||
Sep 13, 2022 | EVP, PRESIDENT DIAGNOSTICS | 44.34 | $231.20 | $10.25K | BUY | 0.31% | 14.28K | Sep 07 | ||
Aug 05, 2022 | CHIEF FINANCIAL OFFICER, EVP | 0.00 | $200.53 | -$3.43M | SELL-OPTIONS | 0.00% | 52.16K | Aug 03 | ||
Aug 03, 2022 | SVP, CHIEF ACCOUNTING OFFICER | -1.78K | $202.49 | -$559.13K | SELL | -48.21% | 1.91K | Aug 01 | ||
Jun 14, 2022 | EVP, PRESIDENT DIAGNOSTICS | 42.01 | $242.19 | $10.17K | BUY | 0.30% | 14.17K | Jun 07 | ||
Mar 31, 2022 | EVP, PRESIDENT-DIAGNOSTICS LAB | -2.36K | $277.11 | -$652.87K | SELL | -26.29% | 6.61K | Mar 29 | ||
Mar 31, 2022 | EVP, CHIEF LEGAL OFFICER | -2.45K | $277.11 | -$678.64K | SELL | -31.66% | 5.29K | Mar 29 | ||
Mar 29, 2022 | DIRECTOR | -572.00 | $272.98 | -$156.14K | SELL | -8.17% | 6.43K | Mar 25 | ||
Mar 14, 2022 | EVP, CHIEF MARKETING OFFICER | -249.00 | $262.21 | -$65.29K | SELL | -49.90% | 250.00 | Mar 10 | ||
Feb 18, 2022 | DIRECTOR | 3.50K | $263.66 | $922.82K | BUY | 51.82% | 10.25K | Feb 16 | ||
Feb 17, 2022 | EVP, PRESIDENT-DIAGNOSTICS LAB | -207.00 | $273.98 | -$56.71K | SELL | -3.04% | 6.61K | Feb 15 | ||
Feb 17, 2022 | EVP, CHIEF LEGAL OFFICER | -207.00 | $273.98 | -$56.71K | SELL | -3.77% | 5.29K | Feb 15 | ||
Feb 08, 2022 | EVP, PRESIDENT-DIAGNOSTICS LAB | 204.00 | $277.42 | -$98.76K | SELL-OPTIONS | 3.19% | 6.61K | Feb 04 - Feb 07 | ||
Feb 08, 2022 | EVP, CHIEF LEGAL OFFICER | 0.00 | $277.41 | -$83.22K | SELL-OPTIONS | 0.00% | 5.29K | Feb 04 - Feb 07 | ||
Feb 04, 2022 | EVP, PRESIDENT-DIAGNOSTICS LAB | 161.00 | $272.40 | -$76.82K | SELL-OPTIONS | 2.58% | 6.40K | Feb 02 - Feb 03 | ||
Feb 04, 2022 | EVP, CHIEF LEGAL OFFICER | 0.00 | $272.18 | -$64.23K | SELL-OPTIONS | 0.00% | 5.29K | Feb 02 - Feb 03 | ||
Dec 17, 2021 | DIRECTOR | -500.00 | $302.26 | -$151.13K | SELL | -7.41% | 6.25K | Dec 15 | ||
Sep 17, 2021 | EVP, CHIEF LEGAL OFFICER | 0.00 | $190.82 | -$953.64K | SELL-OPTIONS | 0.00% | 5.26K | Sep 15 | ||
Jun 09, 2021 | EVP, CHIEF LEGAL OFFICER | 0.00 | $175.71 | -$817.65K | SELL-OPTIONS | 0.00% | 5.24K | Jun 07 | ||
May 10, 2021 | CEO, COVANCE DRUG DEVELOPMENT | -2.50K | $276.55 | -$691.38K | SELL | -24.17% | 7.84K | May 06 | ||
May 05, 2021 | DIRECTOR | 0.00 | $183.82 | -$443.73K | SELL-OPTIONS | 0.00% | 15.57K | May 03 | ||
Apr 01, 2021 | EVP, PRESIDENT-DIAGNOSTICS LAB | -667.00 | $251.88 | -$168.00K | SELL | -11.76% | 5.01K | Mar 30 | ||
Apr 01, 2021 | EVP, CHIEF LEGAL OFFICER | -812.00 | $251.88 | -$204.53K | SELL | -13.42% | 5.24K | Mar 30 | ||
Feb 19, 2021 | SVP, CHIEF ACCOUNTING OFFICER | 453.00 | $199.14 | -$282.00K | SELL-OPTIONS | 86.58% | 976.22 | Feb 12 - Feb 18 | ||
Feb 17, 2021 | EVP, CHIEF LEGAL OFFICER | 207.00 | $237.29 | -$86.85K | SELL-OPTIONS | 4.91% | 4.43K | Feb 12 - Feb 16 | ||
Feb 17, 2021 | EVP, PRESIDENT-DIAGNOSTICS LAB | 187.00 | $237.58 | -$78.40K | SELL-OPTIONS | 4.50% | 4.34K | Feb 12 - Feb 16 | ||
Feb 08, 2021 | EVP, CHIEF LEGAL OFFICER | 108.00 | $224.96 | -$43.19K | SELL-OPTIONS | 2.63% | 4.22K | Feb 04 - Feb 05 | ||
Feb 08, 2021 | EVP, PRESIDENT-DIAGNOSTICS LAB | 203.00 | $224.96 | -$80.31K | SELL-OPTIONS | 5.14% | 4.15K | Feb 04 - Feb 05 | ||
Nov 10, 2020 | — | -588.00 | $214.59 | -$126.18K | SELL | -12.96% | 3.95K | Nov 06 | ||
Nov 06, 2020 | — | -1.50K | $214.14 | -$321.20K | SELL | -16.31% | 7.70K | Nov 04 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.